IDiyas

For the Inventor, By the Inventor

Edison, NJ, United States of America

Thomas L Shih

USPTO Granted Patents = 11

Average Co-Inventor Count = 3.3

ph-index = 6

Forward Citations = 129(Granted Patents)


Location History:

  • Edison, NJ (US) (1989 - 2001)
  • Jackson, NJ (US) (2003)

Company Filing History:

goldMedal11 out of 4,770 
 
Merck + Co., Inc.
 patents

Years Active: 1989-2003

Loading Chart...
11 patents (USPTO):
1. 6586452 - C1 to C4 side chain modified nodulisporic acid analogs (2003-07-01),
2. 6221894 - Nodulisporic acid derivatives (2001-04-24),
3. 5962499 - Nodulisporic acid derivatives (1999-10-05),
4. 5830875 - 24-and 25-substituted avermectin and milbemycin derivatives (1998-11-03),
5. 5789587 - Heterocyclic-fused lactams promote release of growth hormone (1998-08-04),
6. 5705515 - Substituted sulfonamides as selective .beta.-3 agonists for the (1998-01-06),
7. 5606054 - Heterocyclic-fused lactams promote release of growth hormone (1997-02-25),
8. 5561142 - Substituted sulfonamides as selective .beta..sub.3 agonists for the (1996-10-01),
9. 5411946 - Avermectin derivatives (1995-05-02),
10. 4906619 - Alkyl avermectin derivatives (1990-03-06),
11. 4831016 - Reduced avermectin derivatives (1989-05-16),

Title: The Innovative Contributions of Thomas L. Shih

Introduction

Thomas L. Shih is a prominent inventor based in Edison, NJ, known for his significant contributions to the field of pharmaceuticals. With a total of 11 patents to his name, he has made remarkable advancements in the development of novel compounds that serve various medical purposes.

Latest Patents

Among his latest patents are the C1 to C4 side chain modified nodulisporic acid analogs. This invention relates to novel nodulosporic acid derivatives, which are recognized for their acaricidal, antiparasitic, insecticidal, and anthelmintic properties. These derivatives represent a significant step forward in the search for effective treatments in these areas.

Career Highlights

Thomas L. Shih is currently employed at Merck & Company, Inc., a leading global healthcare company. His work at Merck has allowed him to focus on innovative research and development, contributing to the advancement of medical science and the creation of new therapeutic agents.

Collaborations

Throughout his career, Thomas has collaborated with notable colleagues, including Michael H. Fisher and Helmut H. Mrozik. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.

Conclusion

In summary, Thomas L. Shih's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key innovator. His work continues to impact the industry positively, paving the way for future advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…